Navigating the FDA Decision on Resmetirom: The Road Ahead

Описание к видео Navigating the FDA Decision on Resmetirom: The Road Ahead

In the wake of the FDA's decision about a breakthrough NASH treatment in the US, Donna Cryer, JD, GLI founder and CEO, will host a special episode of GLI LIVE with experts in fatty liver disease to talk about the importance of this decision and the road ahead. Let's unpack this news together! Guests for this episode are Dr. Janese Laster, gastroenterologist and founder of Gut Theory Total Digestive Care; Dr. Amreen Dinani, Associate Professor in the Department of Gastroenterology at Duke University; and Louise Campbell, expert hepatology nurse.

Комментарии

Информация по комментариям в разработке

Похожие видео